Table of Content

1 Celiac Disease Drug Market Overview
1.1 Celiac Disease Drug Product Scope
1.2 Celiac Disease Drug Segment by Type
1.2.1 Global Celiac Disease Drug Sales by Type (2016 & 2021 & 2027)
1.2.2 Distension
1.2.3 Diarrhea
1.2.4 Anorexia
1.2.5 Others
1.3 Celiac Disease Drug Segment by Application
1.3.1 Global Celiac Disease Drug Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 First Line of Treatment
1.3.3 Second Line of Treatment
1.4 Celiac Disease Drug Market Estimates and Forecasts (2016-2027)
1.4.1 Global Celiac Disease Drug Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Celiac Disease Drug Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Celiac Disease Drug Price Trends (2016-2027)

2 Celiac Disease Drug Estimates and Forecasts by Region
2.1 Global Celiac Disease Drug Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Celiac Disease Drug Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Celiac Disease Drug Sales Market Share by Region (2016-2021)
2.2.2 Global Celiac Disease Drug Revenue Market Share by Region (2016-2021)
2.3 Global Celiac Disease Drug Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Celiac Disease Drug Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Celiac Disease Drug Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Celiac Disease Drug Estimates and Projections (2016-2027)
2.4.2 Europe Celiac Disease Drug Estimates and Projections (2016-2027)
2.4.3 China Celiac Disease Drug Estimates and Projections (2016-2027)
2.4.4 Japan Celiac Disease Drug Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Celiac Disease Drug Estimates and Projections (2016-2027)
2.4.6 India Celiac Disease Drug Estimates and Projections (2016-2027)

3 Global Celiac Disease Drug Competition Landscape by Players
3.1 Global Top Celiac Disease Drug Players by Sales (2016-2021)
3.2 Global Top Celiac Disease Drug Players by Revenue (2016-2021)
3.3 Global Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Celiac Disease Drug as of 2020)
3.4 Global Celiac Disease Drug Average Price by Company (2016-2021)
3.5 Manufacturers Celiac Disease Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Celiac Disease Drug Market Size by Type
4.1 Global Celiac Disease Drug Historic Market Review by Type (2016-2021)
4.1.1 Global Celiac Disease Drug Sales Market Share by Type (2016-2021)
4.1.2 Global Celiac Disease Drug Revenue Market Share by Type (2016-2021)
4.1.3 Global Celiac Disease Drug Price by Type (2016-2021)
4.2 Global Celiac Disease Drug Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Celiac Disease Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Celiac Disease Drug Revenue Forecast by Type (2022-2027)
4.2.3 Global Celiac Disease Drug Price Forecast by Type (2022-2027)

5 Global Celiac Disease Drug Market Size by Application
5.1 Global Celiac Disease Drug Historic Market Review by Application (2016-2021)
5.1.1 Global Celiac Disease Drug Sales Market Share by Application (2016-2021)
5.1.2 Global Celiac Disease Drug Revenue Market Share by Application (2016-2021)
5.1.3 Global Celiac Disease Drug Price by Application (2016-2021)
5.2 Global Celiac Disease Drug Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Celiac Disease Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Celiac Disease Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Celiac Disease Drug Price Forecast by Application (2022-2027)

6 North America Celiac Disease Drug Market Facts & Figures
6.1 North America Celiac Disease Drug Sales by Company
6.1.1 North America Celiac Disease Drug Sales by Company (2016-2021)
6.1.2 North America Celiac Disease Drug Revenue by Company (2016-2021)
6.2 North America Celiac Disease Drug Sales Breakdown by Type
6.2.1 North America Celiac Disease Drug Sales Breakdown by Type (2016-2021)
6.2.2 North America Celiac Disease Drug Sales Breakdown by Type (2022-2027)
6.3 North America Celiac Disease Drug Sales Breakdown by Application
6.3.1 North America Celiac Disease Drug Sales Breakdown by Application (2016-2021)
6.3.2 North America Celiac Disease Drug Sales Breakdown by Application (2022-2027)

7 Europe Celiac Disease Drug Market Facts & Figures
7.1 Europe Celiac Disease Drug Sales by Company
7.1.1 Europe Celiac Disease Drug Sales by Company (2016-2021)
7.1.2 Europe Celiac Disease Drug Revenue by Company (2016-2021)
7.2 Europe Celiac Disease Drug Sales Breakdown by Type
7.2.1 Europe Celiac Disease Drug Sales Breakdown by Type (2016-2021)
7.2.2 Europe Celiac Disease Drug Sales Breakdown by Type (2022-2027)
7.3 Europe Celiac Disease Drug Sales Breakdown by Application
7.3.1 Europe 138 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 138 Sales Breakdown by Application (2022-2027)

8 China Celiac Disease Drug Market Facts & Figures
8.1 China Celiac Disease Drug Sales by Company
8.1.1 China Celiac Disease Drug Sales by Company (2016-2021)
8.1.2 China Celiac Disease Drug Revenue by Company (2016-2021)
8.2 China Celiac Disease Drug Sales Breakdown by Type
8.2.1 China Celiac Disease Drug Sales Breakdown by Type (2016-2021)
8.2.2 China Celiac Disease Drug Sales Breakdown by Type (2022-2027)
8.3 China Celiac Disease Drug Sales Breakdown by Application
8.3.1 China 163 Sales Breakdown by Application (2016-2021)
8.3.2 China 163 Sales Breakdown by Application (2022-2027)

9 Japan Celiac Disease Drug Market Facts & Figures
9.1 Japan Celiac Disease Drug Sales by Company
9.1.1 Japan Celiac Disease Drug Sales by Company (2016-2021)
9.1.2 Japan Celiac Disease Drug Revenue by Company (2016-2021)
9.2 Japan Celiac Disease Drug Sales Breakdown by Type
9.2.1 Japan Celiac Disease Drug Sales Breakdown by Type (2016-2021)
9.2.2 Japan Celiac Disease Drug Sales Breakdown by Type (2022-2027)
9.3 Japan Celiac Disease Drug Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Celiac Disease Drug Market Facts & Figures
10.1 Southeast Asia Celiac Disease Drug Sales by Company
10.1.1 Southeast Asia Celiac Disease Drug Sales by Company (2016-2021)
10.1.2 Southeast Asia Celiac Disease Drug Revenue by Company (2016-2021)
10.2 Southeast Asia Celiac Disease Drug Sales Breakdown by Type
10.2.1 Southeast Asia Celiac Disease Drug Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Celiac Disease Drug Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Celiac Disease Drug Sales Breakdown by Application
10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027)

11 India Celiac Disease Drug Market Facts & Figures
11.1 India Celiac Disease Drug Sales by Company
11.1.1 India Celiac Disease Drug Sales by Company (2016-2021)
11.1.2 India Celiac Disease Drug Revenue by Company (2016-2021)
11.2 India Celiac Disease Drug Sales Breakdown by Type
11.2.1 India Celiac Disease Drug Sales Breakdown by Type (2016-2021)
11.2.2 India Celiac Disease Drug Sales Breakdown by Type (2022-2027)
11.3 India Celiac Disease Drug Sales Breakdown by Application
11.3.1 India Celiac Disease Drug Sales Breakdown by Application (2016-2021)
11.3.2 India Celiac Disease Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Celiac Disease Drug Business
12.1 F. Hoffmann-La Roche
12.1.1 F. Hoffmann-La Roche Corporation Information
12.1.2 F. Hoffmann-La Roche Business Overview
12.1.3 F. Hoffmann-La Roche Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 F. Hoffmann-La Roche Celiac Disease Drug Products Offered
12.1.5 F. Hoffmann-La Roche Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Corporation Information
12.2.2 Johnson & Johnson Business Overview
12.2.3 Johnson & Johnson Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Johnson & Johnson Celiac Disease Drug Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Celiac Disease Drug Products Offered
12.3.5 Merck Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Celiac Disease Drug Products Offered
12.4.5 Pfizer Recent Development
12.5 ADMA Biologics
12.5.1 ADMA Biologics Corporation Information
12.5.2 ADMA Biologics Business Overview
12.5.3 ADMA Biologics Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 ADMA Biologics Celiac Disease Drug Products Offered
12.5.5 ADMA Biologics Recent Development
12.6 Amgen
12.6.1 Amgen Corporation Information
12.6.2 Amgen Business Overview
12.6.3 Amgen Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Amgen Celiac Disease Drug Products Offered
12.6.5 Amgen Recent Development
12.7 Anthera Pharmaceuticals
12.7.1 Anthera Pharmaceuticals Corporation Information
12.7.2 Anthera Pharmaceuticals Business Overview
12.7.3 Anthera Pharmaceuticals Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Anthera Pharmaceuticals Celiac Disease Drug Products Offered
12.7.5 Anthera Pharmaceuticals Recent Development
12.8 Bayer
12.8.1 Bayer Corporation Information
12.8.2 Bayer Business Overview
12.8.3 Bayer Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bayer Celiac Disease Drug Products Offered
12.8.5 Bayer Recent Development
12.9 Biogen
12.9.1 Biogen Corporation Information
12.9.2 Biogen Business Overview
12.9.3 Biogen Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Biogen Celiac Disease Drug Products Offered
12.9.5 Biogen Recent Development
12.10 BioLineRx
12.10.1 BioLineRx Corporation Information
12.10.2 BioLineRx Business Overview
12.10.3 BioLineRx Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 BioLineRx Celiac Disease Drug Products Offered
12.10.5 BioLineRx Recent Development
12.11 Biotest
12.11.1 Biotest Corporation Information
12.11.2 Biotest Business Overview
12.11.3 Biotest Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Biotest Celiac Disease Drug Products Offered
12.11.5 Biotest Recent Development
12.12 Bristol-Myers Squibb
12.12.1 Bristol-Myers Squibb Corporation Information
12.12.2 Bristol-Myers Squibb Business Overview
12.12.3 Bristol-Myers Squibb Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Bristol-Myers Squibb Celiac Disease Drug Products Offered
12.12.5 Bristol-Myers Squibb Recent Development
12.13 Celgene
12.13.1 Celgene Corporation Information
12.13.2 Celgene Business Overview
12.13.3 Celgene Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Celgene Celiac Disease Drug Products Offered
12.13.5 Celgene Recent Development
12.14 Takeda Pharmaceutical
12.14.1 Takeda Pharmaceutical Corporation Information
12.14.2 Takeda Pharmaceutical Business Overview
12.14.3 Takeda Pharmaceutical Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Takeda Pharmaceutical Celiac Disease Drug Products Offered
12.14.5 Takeda Pharmaceutical Recent Development
12.15 Novartis
12.15.1 Novartis Corporation Information
12.15.2 Novartis Business Overview
12.15.3 Novartis Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Novartis Celiac Disease Drug Products Offered
12.15.5 Novartis Recent Development
12.16 LFB Group
12.16.1 LFB Group Corporation Information
12.16.2 LFB Group Business Overview
12.16.3 LFB Group Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.16.4 LFB Group Celiac Disease Drug Products Offered
12.16.5 LFB Group Recent Development
12.17 Kedrion Biopharma
12.17.1 Kedrion Biopharma Corporation Information
12.17.2 Kedrion Biopharma Business Overview
12.17.3 Kedrion Biopharma Celiac Disease Drug Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Kedrion Biopharma Celiac Disease Drug Products Offered
12.17.5 Kedrion Biopharma Recent Development

13 Celiac Disease Drug Manufacturing Cost Analysis
13.1 Celiac Disease Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Celiac Disease Drug
13.4 Celiac Disease Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Celiac Disease Drug Distributors List
14.3 Celiac Disease Drug Customers

15 Market Dynamics
15.1 Celiac Disease Drug Market Trends
15.2 Celiac Disease Drug Drivers
15.3 Celiac Disease Drug Market Challenges
15.4 Celiac Disease Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Celiac Disease Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Celiac Disease Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Celiac Disease Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Celiac Disease Drug Sales (K Pcs) by Region (2016-2021)
Table 5. Global Celiac Disease Drug Sales Market Share by Region (2016-2021)
Table 6. Global Celiac Disease Drug Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Celiac Disease Drug Revenue Share by Region (2016-2021)
Table 8. Global Celiac Disease Drug Sales (K Pcs) Forecast by Region (2022-2027)
Table 9. Global Celiac Disease Drug Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Celiac Disease Drug Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Celiac Disease Drug Revenue Share Forecast by Region (2022-2027)
Table 12. Global Celiac Disease Drug Sales (K Pcs) of Key Companies (2016-2021)
Table 13. Global Celiac Disease Drug Sales Share by Company (2016-2021)
Table 14. Global Celiac Disease Drug Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Celiac Disease Drug Revenue Share by Company (2016-2021)
Table 16. Global Celiac Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Disease Drug as of 2020)
Table 17. Global Celiac Disease Drug Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Celiac Disease Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Celiac Disease Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Celiac Disease Drug Sales (K Pcs) by Type (2016-2021)
Table 22. Global Celiac Disease Drug Sales Share by Type (2016-2021)
Table 23. Global Celiac Disease Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Celiac Disease Drug Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Celiac Disease Drug Sales Share by Type (2022-2027)
Table 26. Global Celiac Disease Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Celiac Disease Drug Revenue Share by Type (2022-2027)
Table 28. Global Celiac Disease Drug Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Celiac Disease Drug Sales (K Pcs) by Application (2016-2021)
Table 30. Global Celiac Disease Drug Sales Share by Application (2016-2021)
Table 31. Global Celiac Disease Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Celiac Disease Drug Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Celiac Disease Drug Sales (K Pcs) by Application (2022-2027)
Table 34. Global Celiac Disease Drug Sales Share by Application (2022-2027)
Table 35. Global Celiac Disease Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Celiac Disease Drug Revenue Share by Application (2022-2027)
Table 37. Global Celiac Disease Drug Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Celiac Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 39. North America Celiac Disease Drug Sales Market Share by Company (2016-2021)
Table 40. North America Celiac Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Celiac Disease Drug Revenue Market Share by Company (2016-2021)
Table 42. North America Celiac Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 43. North America Celiac Disease Drug Sales Market Share by Type (2016-2021)
Table 44. North America Celiac Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 45. North America Celiac Disease Drug Sales Market Share by Type (2022-2027)
Table 46. North America Celiac Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 47. North America Celiac Disease Drug Sales Market Share by Application (2016-2021)
Table 48. North America Celiac Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 49. North America Celiac Disease Drug Sales Market Share by Application (2022-2027)
Table 50. Europe Celiac Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 51. Europe Celiac Disease Drug Sales Market Share by Company (2016-2021)
Table 52. Europe Celiac Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Celiac Disease Drug Revenue Market Share by Company (2016-2021)
Table 54. Europe Celiac Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 55. Europe Celiac Disease Drug Sales Market Share by Type (2016-2021)
Table 56. Europe Celiac Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 57. Europe Celiac Disease Drug Sales Market Share by Type (2022-2027)
Table 58. Europe Celiac Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 59. Europe Celiac Disease Drug Sales Market Share by Application (2016-2021)
Table 60. Europe Celiac Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 61. Europe Celiac Disease Drug Sales Market Share by Application (2022-2027)
Table 62. China Celiac Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 63. China Celiac Disease Drug Sales Market Share by Company (2016-2021)
Table 64. China Celiac Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Celiac Disease Drug Revenue Market Share by Company (2016-2021)
Table 66. China Celiac Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 67. China Celiac Disease Drug Sales Market Share by Type (2016-2021)
Table 68. China Celiac Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 69. China Celiac Disease Drug Sales Market Share by Type (2022-2027)
Table 70. China Celiac Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 71. China Celiac Disease Drug Sales Market Share by Application (2016-2021)
Table 72. China Celiac Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 73. China Celiac Disease Drug Sales Market Share by Application (2022-2027)
Table 74. Japan Celiac Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 75. Japan Celiac Disease Drug Sales Market Share by Company (2016-2021)
Table 76. Japan Celiac Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Celiac Disease Drug Revenue Market Share by Company (2016-2021)
Table 78. Japan Celiac Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 79. Japan Celiac Disease Drug Sales Market Share by Type (2016-2021)
Table 80. Japan Celiac Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 81. Japan Celiac Disease Drug Sales Market Share by Type (2022-2027)
Table 82. Japan Celiac Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 83. Japan Celiac Disease Drug Sales Market Share by Application (2016-2021)
Table 84. Japan Celiac Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 85. Japan Celiac Disease Drug Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Celiac Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 87. Southeast Asia Celiac Disease Drug Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Celiac Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Celiac Disease Drug Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Celiac Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 91. Southeast Asia Celiac Disease Drug Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Celiac Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 93. Southeast Asia Celiac Disease Drug Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Celiac Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 95. Southeast Asia Celiac Disease Drug Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Celiac Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 97. Southeast Asia Celiac Disease Drug Sales Market Share by Application (2022-2027)
Table 98. India Celiac Disease Drug Sales (K Pcs) by Company (2016-2021)
Table 99. India Celiac Disease Drug Sales Market Share by Company (2016-2021)
Table 100. India Celiac Disease Drug Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Celiac Disease Drug Revenue Market Share by Company (2016-2021)
Table 102. India Celiac Disease Drug Sales by Type (2016-2021) & (K Pcs)
Table 103. India Celiac Disease Drug Sales Market Share by Type (2016-2021)
Table 104. India Celiac Disease Drug Sales by Type (2022-2027) & (K Pcs)
Table 105. India Celiac Disease Drug Sales Market Share by Type (2022-2027)
Table 106. India Celiac Disease Drug Sales by Application (2016-2021) & (K Pcs)
Table 107. India Celiac Disease Drug Sales Market Share by Application (2016-2021)
Table 108. India Celiac Disease Drug Sales by Application (2022-2027) & (K Pcs)
Table 109. India Celiac Disease Drug Sales Market Share by Application (2022-2027)
Table 110. F. Hoffmann-La Roche Corporation Information
Table 111. F. Hoffmann-La Roche Description and Business Overview
Table 112. F. Hoffmann-La Roche Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. F. Hoffmann-La Roche Celiac Disease Drug Product
Table 114. F. Hoffmann-La Roche Recent Development
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Johnson & Johnson Celiac Disease Drug Product
Table 119. Johnson & Johnson Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Merck Celiac Disease Drug Product
Table 124. Merck Recent Development
Table 125. Pfizer Corporation Information
Table 126. Pfizer Description and Business Overview
Table 127. Pfizer Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. Pfizer Celiac Disease Drug Product
Table 129. Pfizer Recent Development
Table 130. ADMA Biologics Corporation Information
Table 131. ADMA Biologics Description and Business Overview
Table 132. ADMA Biologics Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. ADMA Biologics Celiac Disease Drug Product
Table 134. ADMA Biologics Recent Development
Table 135. Amgen Corporation Information
Table 136. Amgen Description and Business Overview
Table 137. Amgen Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Amgen Celiac Disease Drug Product
Table 139. Amgen Recent Development
Table 140. Anthera Pharmaceuticals Corporation Information
Table 141. Anthera Pharmaceuticals Description and Business Overview
Table 142. Anthera Pharmaceuticals Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Anthera Pharmaceuticals Celiac Disease Drug Product
Table 144. Anthera Pharmaceuticals Recent Development
Table 145. Bayer Corporation Information
Table 146. Bayer Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 147. Bayer Description and Business Overview
Table 148. Bayer Celiac Disease Drug Product
Table 149. Bayer Recent Development
Table 150. Biogen Corporation Information
Table 151. Biogen Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 152. Biogen Description and Business Overview
Table 153. Biogen Celiac Disease Drug Product
Table 154. Biogen Recent Development
Table 155. BioLineRx Corporation Information
Table 156. BioLineRx Description and Business Overview
Table 157. BioLineRx Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 158. BioLineRx Celiac Disease Drug Product
Table 159. BioLineRx Recent Development
Table 160. Biotest Corporation Information
Table 161. Biotest Description and Business Overview
Table 162. Biotest Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 163. Biotest Celiac Disease Drug Product
Table 164. Biotest Recent Development
Table 165. Bristol-Myers Squibb Corporation Information
Table 166. Bristol-Myers Squibb Description and Business Overview
Table 167. Bristol-Myers Squibb Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 168. Bristol-Myers Squibb Celiac Disease Drug Product
Table 169. Bristol-Myers Squibb Recent Development
Table 170. Celgene Corporation Information
Table 171. Celgene Description and Business Overview
Table 172. Celgene Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 173. Celgene Celiac Disease Drug Product
Table 174. Celgene Recent Development
Table 175. Takeda Pharmaceutical Corporation Information
Table 176. Takeda Pharmaceutical Description and Business Overview
Table 177. Takeda Pharmaceutical Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 178. Takeda Pharmaceutical Celiac Disease Drug Product
Table 179. Takeda Pharmaceutical Recent Development
Table 180. Novartis Corporation Information
Table 181. Novartis Description and Business Overview
Table 182. Novartis Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 183. Novartis Celiac Disease Drug Product
Table 184. Novartis Recent Development
Table 185. LFB Group Corporation Information
Table 186. LFB Group Description and Business Overview
Table 187. LFB Group Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 188. LFB Group Celiac Disease Drug Product
Table 189. LFB Group Recent Development
Table 190. Kedrion Biopharma Corporation Information
Table 191. Kedrion Biopharma Description and Business Overview
Table 192. Kedrion Biopharma Celiac Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 193. Kedrion Biopharma Celiac Disease Drug Product
Table 194. Kedrion Biopharma Recent Development
Table 195. Production Base and Market Concentration Rate of Raw Material
Table 196. Key Suppliers of Raw Materials
Table 197. Celiac Disease Drug Distributors List
Table 198. Celiac Disease Drug Customers List
Table 199. Celiac Disease Drug Market Trends
Table 200. Celiac Disease Drug Market Drivers
Table 201. Celiac Disease Drug Market Challenges
Table 202. Celiac Disease Drug Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Celiac Disease Drug Product Picture
Figure 2. Global Celiac Disease Drug Sales Market Share by Type in 2021 & 2027
Figure 3. Distension Product Picture
Figure 4. Diarrhea Product Picture
Figure 5. Anorexia Product Picture
Figure 6. Others Product Picture
Figure 7. Global Celiac Disease Drug Sales Market Share by Application in 2021 & 2027
Figure 8. First Line of Treatment Examples
Figure 9. Second Line of Treatment Examples
Figure 10. Global Celiac Disease Drug Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Celiac Disease Drug Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Celiac Disease Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 13. Global Celiac Disease Drug Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 14. Global Celiac Disease Drug Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Celiac Disease Drug Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Celiac Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Celiac Disease Drug Sales (K Pcs) Growth Rate (2016-2027)
Figure 18. Europe Celiac Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Celiac Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Celiac Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Celiac Disease Drug Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Celiac Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Celiac Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Celiac Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Celiac Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Celiac Disease Drug Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Celiac Disease Drug Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Celiac Disease Drug Players Market Share by Revenue in Celiac Disease Drug: 2016 & 2020
Figure 29. Celiac Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Celiac Disease Drug Revenue Share by Type (2016-2021)
Figure 31. Global Celiac Disease Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Celiac Disease Drug Revenue Share by Application (2016-2021)
Figure 33. Global Celiac Disease Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Celiac Disease Drug Sales Market Share by Type in 2020
Figure 35. North America Celiac Disease Drug Sales Market Share by Application in 2020
Figure 36. Europe Celiac Disease Drug Sales Market Share by Type in 2020
Figure 37. Europe Celiac Disease Drug Sales Market Share by Application in 2020
Figure 38. China Celiac Disease Drug Sales Market Share by Type in 2020
Figure 39. China Celiac Disease Drug Sales Market Share by Application in 2020
Figure 40. Japan Celiac Disease Drug Sales Market Share by Type in 2020
Figure 41. Japan Celiac Disease Drug Sales Market Share by Application in 2020
Figure 42. Southeast Asia Celiac Disease Drug Sales Market Share by Type in 2020
Figure 43. Southeast Asia Celiac Disease Drug Sales Market Share by Application in 2020
Figure 44. India Celiac Disease Drug Sales Market Share by Type in 2020
Figure 45. India Celiac Disease Drug Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Celiac Disease Drug
Figure 48. Manufacturing Process Analysis of Celiac Disease Drug
Figure 49. Celiac Disease Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed